iBio voluntarily delists from NYSE American, lists on Nasdaq Capital Market effective March 4, 2025

iBio, Inc.

Board authorized voluntary withdrawal from NYSE American and listing on Nasdaq Capital Market on Feb 19, 2025.
Last NYSE American trade expected at market close March 3, 2025; Nasdaq trading starts market open March 4, 2025.
Ticker symbol 'IBIO' remains unchanged on both exchanges.
CEO Martin Brenner says move expected to improve stock visibility, trading liquidity, and institutional investor exposure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.